Ghrelin mimetic peptides are synthetic compounds designed to replicate the physiological actions of the endogenous hunger hormone, ghrelin, by binding to and activating the Growth Hormone Secretagogue Receptor (GHSR-1a). Clinically, these agents are investigated for their potential to stimulate appetite and promote positive energy balance, particularly in cachectic or hypophagic states. They directly engage the central mechanisms controlling satiety signals.
Origin
The term is constructed from ghrelin, the naturally occurring peptide hormone primarily produced by the stomach, and mimetic, meaning imitative. Their origin in research stemmed from the desire to pharmacologically harness ghrelin’s potent orexigenic effects for therapeutic application. This reflects a targeted approach to manipulating the gut-brain axis.
Mechanism
These peptides function by crossing the blood-brain barrier or signaling through vagal afferents to stimulate neuropeptide Y (NPY) and Agouti-related peptide (AgRP) neurons in the arcuate nucleus of the hypothalamus. This activation promotes feeding behavior and stimulates the release of growth hormone. Unlike ghrelin itself, mimetics are often engineered for enhanced stability and prolonged receptor interaction, offering a sustained signal for energy intake regulation.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.